<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0019293"><a href="http://purl.obolibrary.org/obo/MONDO_0019293">MONDO:0019293</a></h3>
<p><strong>Label:</strong> skin vascular disease</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019180">MONDO:0019180</a> (hereditary hemorrhagic telangiectasia), <a href="http://purl.obolibrary.org/obo/MONDO_0019557">MONDO:0019557</a> (Chilblain lupus), <a href="http://purl.obolibrary.org/obo/MONDO_0007864">MONDO:0007864</a> (Klippel-Trenaunay syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0011457">MONDO:0011457</a> (ataxia-telangiectasia-like disorder), <a href="http://purl.obolibrary.org/obo/MONDO_0008840">MONDO:0008840</a> (ataxia telangiectasia), <a href="http://purl.obolibrary.org/obo/MONDO_0012017">MONDO:0012017</a> (Parkes Weber syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0019803">MONDO:0019803</a> (angioma serpiginosum),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_100">Orphanet:100</a>, <a href="http://purl.obolibrary.org/obo/OMIM_106050">OMIM:106050</a>, <a href="http://purl.obolibrary.org/obo/OMIM_601101">OMIM:601101</a>, <a href="http://purl.obolibrary.org/obo/OMIM_187300">OMIM:187300</a>, <a href="http://purl.obolibrary.org/obo/OMIM_600376">OMIM:600376</a>, <a href="http://www.orpha.net/ORDO/Orphanet_90280">Orphanet:90280</a>, <a href="http://www.orpha.net/ORDO/Orphanet_90308">Orphanet:90308</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300652">OMIM:300652</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2346">Orphanet:2346</a>, <a href="http://www.orpha.net/ORDO/Orphanet_95429">Orphanet:95429</a>, <a href="http://www.orpha.net/ORDO/Orphanet_251347">Orphanet:251347</a>, <a href="http://purl.obolibrary.org/obo/OMIM_208910">OMIM:208910</a>, <a href="http://purl.obolibrary.org/obo/OMIM_149000">OMIM:149000</a>, <a href="http://purl.obolibrary.org/obo/OMIM_208900">OMIM:208900</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614415">OMIM:614415</a>, <a href="http://www.orpha.net/ORDO/Orphanet_90307">Orphanet:90307</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610655">OMIM:610655</a>, <a href="http://purl.obolibrary.org/obo/OMIM_608355">OMIM:608355</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615506">OMIM:615506</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610448">OMIM:610448</a>, <a href="http://purl.obolibrary.org/obo/OMIM_604391">OMIM:604391</a>, <a href="http://www.orpha.net/ORDO/Orphanet_774">Orphanet:774</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and <a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 59.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012759">HP:0012759</a> (Neurodevelopmental abnormality))) 59.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0009830">HP:0009830</a> (Peripheral neuropathy))) 59.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0004328">HP:0004328</a> (Abnormality of the anterior segment of the globe))) 59.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002683">HP:0002683</a> (Abnormality of the calvaria))) 59.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001311">HP:0001311</a> (Abnormal nervous system electrophysiology))) 59.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001249">HP:0001249</a> (Intellectual disability))) 59.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000759">HP:0000759</a> (Abnormal peripheral nervous system morphology))) 59.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000492">HP:0000492</a> (Abnormality of the eyelid))) 59.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000164">HP:0000164</a> (Abnormality of the dentition))) 59.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and <a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) and <a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology) 59.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and <a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) 59.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and <a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) and <a href="http://purl.obolibrary.org/obo/HP_0012443">HP:0012443</a> (Abnormality of brain morphology) 59.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and <a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) and <a href="http://purl.obolibrary.org/obo/HP_0002011">HP:0002011</a> (Morphological abnormality of the central nervous system) 59.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000524">HP:0000524</a> (Conjunctival telangiectasia) and <a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system) and <a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 59.93%</li>
</ul>
</body>
</html>
